Related Articles
Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line
Antitumor activity of a novel small molecule STAT3 inhibitor against a human lymphoma cell line with high STAT3 activation
GSK‑3 inhibitor CHIR99021 enriches glioma stem‑like cells
YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line
Stem cell markers in glioma progression and recurrence